Back to search
FDAFDA · Food and drugs·Recall number Z-1041-2023

Mammotome MammoStar Biopsy Site Identified, REF STAR1401

Published February 8, 2023 · Recall initiated: December 16, 2022

Summary

FDA records medical device Class II recall Z-1041-2023, published February 8, 2023 and initiated December 16, 2022. Recalling firm: Carbon Medical Technologies, Inc.; Status: Terminated; Reported quantity: 550 devices; Lot: UDI/DI 00858015005431, Lot Number 2201011A. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

The label incorrectly identifies the product as STAR1401, a 1x3mm Barbell shaped marker pre-loaded in a 14 gauge needle, while the packaging contains STAR1402, a 1x5mm Tribell shaped marker pre-loaded in a 14 gauge needle.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Carbon Medical Technologies, Inc.
Distributor
US Nationwide distribution in the state of OHIO.
Lot
UDI/DI 00858015005431, Lot Number 2201011A
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Mammotome MammoStar Biopsy Site Identified, REF STAR1401 recalled?

Yes. FDA published recall Z-1041-2023 on February 8, 2023. Reported hazard: The label incorrectly identifies the product as STAR1401, a 1x3mm Barbell shaped marker pre-loaded in a 14 gauge needle, while the packaging contains STAR1402, a 1x5mm Tribell shaped marker pre-loaded in a 14 gauge needle.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail